Wells Fargo & Company Bridge Bio Pharma, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 88,000 shares of BBIO stock, worth $3.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

88,000

Previous 69,678 26.3%

Holding current value

$3.19 Million

Previous $1.77 Million 36.08%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$22.35 - $29.5 $409,496 - $540,499	18,322 Added 26.3%	88,000 $2.41 Million
Q3 2024 Nov 13, 2024	SELL	$23.91 - $31.3 $48,537 - $63,539	-2,030 Reduced 2.83%	69,678 $1.77 Million
Q2 2024 Aug 13, 2024	BUY	$23.0 - $31.04 $377,453 - $509,397	16,411 Added 29.68%	71,708 $1.82 Million
Q1 2024 May 10, 2024	BUY	$27.35 - $40.45 $237,562 - $351,348	8,686 Added 18.64%	55,297 $1.71 Million
Q4 2023 Feb 09, 2024	SELL	$24.02 - $43.89 $872,214 - $1.59 Million	-36,312 Reduced 43.79%	46,611 $1.88 Million
Q3 2023 Nov 13, 2023	SELL	$16.89 - $35.01 $899,257 - $1.86 Million	-53,242 Reduced 39.1%	82,923 $2.19 Million
Q2 2023 Aug 15, 2023	BUY	$13.29 - $18.01 $934,286 - $1.27 Million	70,300 Added 106.73%	136,165 $2.34 Million
Q1 2023 May 12, 2023	BUY	$7.17 - $18.55 $462,421 - $1.2 Million	64,494 Added 4704.16%	65,865 $1.09 Million
Q4 2022 Feb 13, 2023	SELL	$6.74 - $11.52 $33,437 - $57,150	-4,961 Reduced 78.35%	1,371 $10,000
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $17,857 - $27,797	-2,249 Reduced 26.21%	6,332 $62,000
Q2 2022 Aug 12, 2022	SELL	$5.21 - $12.14 $139,299 - $324,587	-26,737 Reduced 75.7%	8,581 $77,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $289,423 - $676,635	-39,431 Reduced 52.75%	35,318 $359,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $74,573 - $349,995	6,553 Added 9.61%	74,749 $1.25 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $1.48 Million - $2.03 Million	31,585 Added 86.27%	68,196 $3.2 Million
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $2.42 Million - $3.34 Million	-52,179 Reduced 58.77%	36,611 $2.23 Million
Q1 2021 May 13, 2021	BUY	$55.47 - $72.35 $901,664 - $1.18 Million	16,255 Added 22.41%	88,790 $5.47 Million
Q4 2020 Feb 09, 2021	BUY	$38.38 - $71.11 $1.22 Million - $2.27 Million	31,879 Added 78.41%	72,535 $5.16 Million
Q3 2020 Nov 05, 2020	SELL	$27.2 - $42.19 $182,729 - $283,432	-6,718 Reduced 14.18%	40,656 $1.53 Million
Q2 2020 Aug 13, 2020	BUY	$22.22 - $35.69 $198,935 - $319,532	8,953 Added 23.3%	47,374 $1.55 Million
Q1 2020 May 14, 2020	BUY	$16.11 - $36.23 $618,962 - $1.39 Million	38,421 New	38,421 $1.11 Million

Others Institutions Holding BBIO

# of Institutions

321

Shares Held

176M

Call Options Held

13M

Put Options Held

2.48M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.38B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Bridge Bio Pharma, Inc. Transaction History